WKHS Locations

Clinical Trials

NCIC CTG Trial MA 21

Study Title

NCIC CTG Trial MA 21

Purpose

Therapy for premenopausal women and early postmenopausal women who have had surgery for high risk breast cancer.

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

Robert Nickelson, M.D.

IRB:

Willis-Knighton

IRB Number:

01.0223

Trial Type:

Device

Sponsor:

National Cancer (NCIC)

Contact Information:

Hematology Oncology Associates
(318) 212-3702
http://cancer.wkhs.com